U.S. FDA Envisions Many Regulatory Coalitions Dealing With Globalization Issues
This article was originally published in PharmAsia News
U.S. FDA could help create several international coalitions to carry out its new globalization plan, which could allow for issue-specific groups focused on individual pharmaceutical sectors
You may also be interested in...
Steve Lynn, director of CDER’s Office of Manufacturing and Product Quality, will take an executive global compliance position.
Opened as part of the globalization initiative, U.S. FDA’s presence in the Middle East and North Africa will shut down in late December in an apparent cost-cutting effort.
The agency is waiting for approval to locate 10 new drug inspectors in China.